Guo Mei

Guo Mei (Chinese: 郭梅; pinyin: Guo Mei, born January, 1968) is a hematologist and associate director of 307th Hospital of Chinese People’s Liberation Army and deputy director of Radiation Research Institute.[1][2][3][4]

For the Chinese Olympic rower, see Guo Mei (rower).
This is a Chinese name; the family name is Guo.

Guo Mei is a Chinese physician who works with Huisheng Ai. She graduated from Academy of Military Medical Sciences and got master degree in 1997. She is a pre-eminent expert in the use of hematopoietic stem cell transplantation for treating radiation injuries and blood disease, especially leukemia, aplastic anemia and myelodysplastic syndrome.[5][6][7][8][9][10]

She is one of the founders of microtransplantation. Years of education and research experience in microtransplantation have earned her a large amount of respect from her colleagues. Her expertise is reflected in the awards and recognition she has received.[11]

Guo Mei brings her passion and knowledge for treating blood disease with microtransplantation in 307th Hospital, and with an equally dedicated medical and support team, works hard every day to improve the quality of lives of the patients.

Research

1998 Dr. Guo and her medical team developed "Study of HLA-matched nonmyeloablative transplantation in the treatment of hematological malignancies" successfully.

2004 The study of HLA haploidentical blood related and unrelated matched donors nonmyeloablative transplantation for the treatment of blood diseases.

2005 Treatment of Jining serious radiation accidents and extremely severe bone marrow and intestinal radiation

2006 Developed an original creativity of microtransplantation for the treatment of leukemia. This technology opens up new opportunities for treating leukemia in world.

From 2010 to 2015, she took part in 12 projects of national 863 and provincial projects. As the first applicants, she took five scientific research projects, including the National Ministry of science and Technology Department project, National 11th Five-Year Plan key project of scientific and technological and National 12th Five-Year Plan key project of scientific and technological.[12]

Honours
  • First prize of military medical achievement award in June 2005
  • Military medical achievement award in March 2006
  • Second prize of military medical achievement award in September 2007
  • Honourable title of the 3rd merit in 2008

Her accomplishments include over 100 published research articles, including four articles that have been recorded by SCI (JCO: 18.4, Blood: 10.55, BBMT 3.86) aplastic anemia and myelodysplastic syndrome.[13][14][15] She has co-authored five monographs, including "Hematopoietic stem cell transplantation clinical and basic," "Modern leukemia study," "Clinical and basic research of radiation sickness," and two more books.

Academic papers
gollark: https://tiddlywiki.com/This is a COOL THING!
gollark: I suppose I *could* add `~/AutoBotRobot/data.sqlite3` or whatever it is to the important things list.
gollark: I at least have sort-of-backups run constantly (important data is replicated to three of my devices), although that's not very good and I should improve it, and - more importantly - AutoBotRobot isn't considered "important".
gollark: So very bad then.
gollark: How good are your backups?

References
  1. Deputy director of Hematology Department, 307 Hospital of PLA
  2. Member of the medical team of MST Leukemia Clinic
  3. Micro transplantation for treatment of leukemia: “way” to solve the matching problem
  4. Micro transplantation for treatment of leukemia “way”
  5. HLA-Mismatched Stem-Cell Microtransplantation As Postremission Therapy for Acute Myeloid Leukemia: Long-Term Follow-Up. J Clin Oncol doi:10.1200/JC0.2012.42.0281.
  6. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.Blood 117:936-941 2011
  7. Establishment and identification of a H-2 completely mismatched microtransplantation model of leukemia mouse.Journal of Exerperimental Hematology 2014, v.22; No.109(03) 779-784.
  8. Changes of Lymphocyte Subsets in Acute Leukemia Patients after HLA-mismatched Nonmyeloablative Hematopoietic Stem Cell Transplantation 17 (6) Journal of Experimental Hematology.
  9. Wei, L; Ai, HS (2009). "[Factors influencing graft versus leukemia effect -- review]". Zhongguo Shi Yan Xue Ye Xue Za Zhi. 17: 844–6. PMID 19549421.
  10. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: Successful engraftment and mild GVHD. Biol Blood Marrow Transplant 15:930-937, 2009.
  11. Member of the medical team of MST Leukemia Clinic
  12. Doctor Guo at the largest interactive medical platform in China
  13. Prophylactic G-CSF mobilized donor lymphocytes infusion after non-myeloablative stem celltransplantation prevents relapse in patients with high-risk leukemia, Chinese Journal of Hematology 2013 Vol. 34 (11): 922-925.
  14. Microtransplantation for treatment of Burkitt lymphoma (2013), Chinese Journal of Hematology 2013 Vol. 34 (10): 912-912.
  15. Cotransplant of HLA haploidentical peripehral blood stem cells and mesenchymal stem cells to treat a child with severe aplastic anemia, Chinese Journal of Hematology 2012 Vol. 33 (3): 242-242.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.